{"id":"https://openalex.org/W3013833338","doi":"https://doi.org/10.1158/1538-7445.sabcs19-pd2-05","title":"Abstract PD2-05: Differential mechanisms of acquired resistance to abemaciclib versus palbociclib reveal novel therapeutic strategies for CDK4/6 therapy-resistant breast cancers","display_name":"Abstract PD2-05: Differential mechanisms of acquired resistance to abemaciclib versus palbociclib reveal novel therapeutic strategies for CDK4/6 therapy-resistant breast cancers","publication_year":2020,"publication_date":"2020-02-15","ids":{"openalex":"https://openalex.org/W3013833338","doi":"https://doi.org/10.1158/1538-7445.sabcs19-pd2-05","mag":"3013833338"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs19-pd2-05","doi":"https://doi.org/10.1158/1538-7445.sabcs19-pd2-05","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs19-pd2-05","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017644527","display_name":"Juliana Navarro-Yepes","orcid":"https://orcid.org/0000-0003-0393-3773","observed_orcids":["https://orcid.org/0000-0003-0393-3773"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Juliana Navarro-Yepes","raw_affiliation_strings":["1Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100422524","display_name":"Xian Chen","orcid":"https://orcid.org/0000-0002-0731-8930","observed_orcids":["https://orcid.org/0000-0002-0731-8930","https://orcid.org/0009-0008-9603-2715"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xian Chen","raw_affiliation_strings":["1Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000113218","display_name":"Tuyen N. Bui","orcid":"https://orcid.org/0000-0001-8509-3653","observed_orcids":["https://orcid.org/0000-0001-8509-3653"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tuyen Bui","raw_affiliation_strings":["1Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026936750","display_name":"Nicole M. Kettner","orcid":"https://orcid.org/0000-0003-2043-4407","observed_orcids":["https://orcid.org/0000-0003-2043-4407"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicole M Kettner","raw_affiliation_strings":["1Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017411324","display_name":"Kelly K. Hunt","orcid":"https://orcid.org/0000-0001-9156-8723","observed_orcids":["https://orcid.org/0000-0001-9156-8723"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelly K Hunt","raw_affiliation_strings":["2Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042960706","display_name":"Khandan Keyomarsi","orcid":"https://orcid.org/0000-0002-5440-0849","observed_orcids":["https://orcid.org/0000-0002-5440-0849"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Khandan Keyomarsi","raw_affiliation_strings":["1Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"4_Supplement","first_page":"PD2","last_page":"05"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abemaciclib","display_name":"abemaciclib","score":0.9480000138282776},{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.9810000061988831},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.8539999723434448},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.968999981880188},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.652999997138977},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.7549999952316284},{"id":"https://openalex.org/keywords/ribociclib","display_name":"ribociclib","score":0.6610000133514404},{"id":"https://openalex.org/keywords/cyclin-e","display_name":"cyclin E","score":0.7419999837875366},{"id":"https://openalex.org/keywords/cdk2","display_name":"CDK2","score":0.6759999990463257},{"id":"https://openalex.org/keywords/glycogen-synthase-kinase-3","display_name":"glycogen synthase kinase-3","score":0.7049999833106995},{"id":"https://openalex.org/keywords/calcium-calmodulin-dependent-protein-kinase-ii","display_name":"calcium/calmodulin-dependent protein kinase II","score":0.6980000138282776},{"id":"https://openalex.org/keywords/endocrine-resistance","display_name":"endocrine therapy resistance","score":0.41499999165534973}],"concepts":[{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.9968632459640503},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7395113110542297},{"id":"https://openalex.org/C124320809","wikidata":"https://www.wikidata.org/wiki/Q46292","display_name":"Cyclin-dependent kinase","level":4,"score":0.6252318620681763},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5338510274887085},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5270155668258667},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.506187379360199},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4893578886985779},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4809255301952362},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4702516794204712},{"id":"https://openalex.org/C51853150","wikidata":"https://www.wikidata.org/wiki/Q14911754","display_name":"Cyclin-dependent kinase 4","level":5,"score":0.45917558670043945},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4332556426525116},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.2572082579135895},{"id":"https://openalex.org/C82495950","wikidata":"https://www.wikidata.org/wiki/Q14911732","display_name":"Cyclin-dependent kinase 2","level":4,"score":0.08384540677070618}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs19-pd2-05","doi":"https://doi.org/10.1158/1538-7445.sabcs19-pd2-05","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs19-pd2-05","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4282935358","https://openalex.org/W4396587858","https://openalex.org/W4382541721","https://openalex.org/W3013500592","https://openalex.org/W4205928549","https://openalex.org/W4292866406","https://openalex.org/W4411287310","https://openalex.org/W4408445370","https://openalex.org/W4412974562","https://openalex.org/W3082042358"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Hormone":[2],"receptor":[3,9],"positive":[4],"(HR+)/human":[5],"epidermal":[6],"growth":[7,118,475],"factor":[8],"2":[10],"negative":[11],"(Her2-)":[12],"is":[13],"the":[14,24,44,59,71,87,346,355,428,465,469,473,554],"most":[15],"prevalent":[16],"subtype":[17],"of":[18,23,46,75,178,197,273,281,313,327,333,376,430,445,454,459,534,553],"breast":[19,49,191,513,548],"cancer,":[20],"representing":[21],"70%":[22],"cases":[25],"with":[26,194,242],"metastatic":[27],"disease.":[28],"Endocrine":[29],"therapy":[30,402,510],"plus":[31,407],"FDA-approved":[32],"cyclin-dependent":[33],"kinases":[34,96],"(CDK)":[35],"4/6":[36],"inhibitors":[37,85,307,509],"(palbociclib,":[38],"ribociclib":[39],"and":[40,62,107,154,186,230,233,261,277,284,303,309,329,366,432,449,457,477,489],"abemaciclib)":[41],"have":[42,86],"improved":[43],"treatment":[45,76,471],"HR+/Her2-":[47],"advanced":[48],"cancer":[50,192,514],"patients.":[51,515],"However,":[52,371],"patients":[53],"develop":[54],"clinical":[55],"resistance":[56,137,179,250,447,492,511,536],"(acquired)":[57],"during":[58],"long-term":[60],"treatment,":[61],"in":[63,119,123,212,214,287,291,320,340,349,354,363,381,386,392,434,512],"some":[64],"cases,":[65],"they":[66],"do":[67],"not":[68,99,391],"respond":[69],"within":[70],"first":[72],"3":[73],"months":[74],"(intrinsic":[77],"resistance),":[78],"leading":[79],"to":[80,115,152,167,175,180,207,247,301,305,345,416,506,537],"disease":[81],"progression.":[82],"Although":[83],"these":[84,158,460],"same":[88,466],"nominal":[89],"targets,":[90],"CDK4/6,":[91],"abemaciclib":[92,111,143,225,302,314,341,387,408,431,490,538],"can":[93,161,503],"inhibit":[94,116],"other":[95,418],"that":[97,131,441,485],"are":[98,126,138,442],"inhibited":[100],"by":[101,257,323],"palbociclib/ribociclib,":[102],"such":[103,497],"as":[104,164,498],"CDK9/7/2/1,":[105],"GSK3\u03b1/\u03b2":[106],"CAMK2\u03b3/\u03b4.":[108],"As":[109,353],"such,":[110],"has":[112],"been":[113],"shown":[114],"cell":[117,420],"Rb":[120],"deficient":[121],"cells,":[122,294,358,389],"which":[124,295,502],"palbociclib/ribociclib":[125],"ineffective.":[127],"Therefore,":[128,396],"we":[129,397,426],"hypothesized":[130],"1)":[132,184],"mechanisms":[133,177,486,533],"driving":[134],"palbociclib":[135,146,189,248,292,350,356,393,411,446,488,540],"acquired":[136,249,491,535],"distinct":[139],"than":[140,419],"those":[141],"mediating":[142],"resistance,":[144],"2)":[145,223],"resistant":[147,190,226,293,300,315,342,351,357,388,394,412],"models":[148,174,413,440],"may":[149],"be":[150,162,504],"responsive":[151,415],"abemaciclib,":[153],"3)":[155,234],"pathways":[156,406],"underlying":[157],"mechanistic":[159],"differences":[160],"exploited":[163,505],"alternative":[165],"therapies":[166],"overcome":[168,507],"resistance.":[169],"Methods:":[170],"We":[171],"generated":[172,437],"several":[173],"examine":[176],"different":[181],"CDK4/6":[182,508,546],"inhibitors:":[183],"MCF7":[185,224],"T47D":[187],"(ER+)":[188],"cells":[193,227,316,343,448],"increasing":[195],"concentrations":[196,211],"palbociclib,":[198],"starting":[199],"at":[200],"1.2":[201],"\u00b5M":[202,209],"(initial":[203],"IC":[204],"50)":[205],"up":[206],"5":[208],"(plasma":[210],"patients)":[213],"a":[215,219,243,269,288,324,330,359,373,382,400,451],"stepwise":[216,289,383],"manner":[217,384],"over":[218],"6":[220],"month":[221],"period,":[222],"(0.5,":[228],"1":[229],"1.5":[231],"\u00b5M),":[232],"organoids":[235],"derived":[236,239],"from":[237,438],"patient":[238],"xenografts":[240],"(PDXs)":[241],"similar":[244],"molecular":[245],"profile":[246],"models.":[251],"Cell":[252],"cycle":[253,421],"changes":[254],"were":[255,296,337,368],"evaluated":[256,398],"western":[258],"blot":[259,266],"analysis":[260,267,312],"flow":[262],"cytometry.":[263],"Results:":[264],"Western":[265],"revealed":[268],"dose":[270,360],"dependent":[271,361],"downregulation":[272],"ER\u03b1,":[274],"Rb,":[275],"p-Rb":[276,328],"p27,":[278],"while":[279],"levels":[280,336],"cyclin":[282,364],"E":[283,365],"p-CDK2":[285,367],"increased":[286,478],"fashion":[290],"only":[297,385],"partially":[298],"cross":[299],"sensitive":[304],"CDK9":[306],"LDC067":[308],"SNS032.":[310],"FACS":[311],"showed":[317],"an":[318],"increase":[319,362],"G2/M":[321],"accompanied":[322],"drastic":[325],"reduction":[326,453],"gradual":[331],"decrease":[332],"Rb.":[334],"ER\u03b1":[335],"slightly":[338],"decreased":[339],"compared":[344],"complete":[347],"loss":[348],"cells.":[352,395],"also":[369],"observed.":[370],"Rad51,":[372],"key":[374],"mediator":[375],"DNA":[377,404,499],"repair,":[378],"was":[379],"downregulated":[380],"but":[390],"if":[399],"combination":[401,429],"targeting":[403],"repair":[405],"could":[409],"render":[410],"more":[414],"targets":[417],"inhibitors.":[422],"To":[423],"this":[424],"end,":[425],"examined":[427],"niraparib":[433],"organoid":[435],"cultures":[436],"PDX":[439,467],"transcriptomic":[443],"surrogates":[444],"found":[450],"significant":[452],"viability,":[455],"number":[456],"density":[458],"organoids.":[461],"In":[462],"vivo,":[463],"using":[464],"models,":[468],"combined":[470],"reduced":[472],"tumor":[474],"rate":[476],"overall":[479],"survival.":[480],"Conclusion:":[481],"Our":[482],"results":[483],"suggest":[484],"underlaying":[487],"exhibit":[493],"differentially":[494],"altered":[495],"pathways,":[496,501],"damage/repair":[500],"Citation":[516],"Format:":[517],"Juliana":[518],"Navarro-Yepes,":[519],"Xian":[520],"Chen,":[521],"Tuyen":[522],"Bui,":[523],"Nicole":[524],"M":[525],"Kettner,":[526],"Kelly":[527],"K":[528],"Hunt,":[529],"Khandan":[530],"Keyomarsi.":[531],"Differential":[532],"versus":[539],"reveal":[541],"novel":[542],"therapeutic":[543],"strategies":[544],"for":[545],"therapy-resistant":[547],"cancers":[549],"[abstract].":[550],"In:":[551],"Proceedings":[552],"2019":[555,561],"San":[556,564],"Antonio":[557],"Breast":[558],"Cancer":[559,570],"Symposium;":[560],"Dec":[562],"10-14;":[563],"Antonio,":[565],"TX.":[566],"Philadelphia":[567],"(PA):":[568],"AACR;":[569],"Res":[571],"2020;80(4":[572],"Suppl):Abstract":[573],"nr":[574],"PD2-05.":[575]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2020-04-03T00:00:00"}